ACCESSION: MSBNK-SMB_Measured-HSA001P0167006
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 40
COMMENT: RAW_SPEC {'2_posi_4346': {'bp': 557526.0, 'sum': 819086.0}, 'ProcedureBlank_4429': {'bp': 532679.0, 'sum': 784987.0}, '16_posi_4386': {'bp': 525599.0, 'sum': 783311.0}, '1_posi_4321': {'bp': 522523.0, 'sum': 782826.0}, 'ProcedureBlank_4345': {'bp': 519761.0, 'sum': 741921.0}, '14_posi_4366': {'bp': 517925.0, 'sum': 778817.0}, '11_posi_4325': {'bp': 515843.0, 'sum': 935626.0}, '3_posi_4343': {'bp': 509444.0, 'sum': 789247.0}, '17_posi_4365': {'bp': 502956.0, 'sum': 950276.0}, '19_posi_4429': {'bp': 499211.0, 'sum': 851456.0}, '1_posi_4404': {'bp': 496618.0, 'sum': 743866.0}, '12_posi_4346': {'bp': 496359.0, 'sum': 796624.0}, '10_posi_4429': {'bp': 493881.0, 'sum': 706748.0}, '15_posi_4386': {'bp': 488530.0, 'sum': 691130.0}, '6_posi_4386': {'bp': 488505.0, 'sum': 687607.0}, '5_posi_4406': {'bp': 484834.0, 'sum': 705997.0}, '13_posi_4325': {'bp': 484439.0, 'sum': 910808.0}, '4_posi_4346': {'bp': 482449.0, 'sum': 718853.0}, '7_posi_4385': {'bp': 480627.0, 'sum': 677586.0}, '9_posi_4430': {'bp': 479903.0, 'sum': 707496.0}, '5_posi_4320': {'bp': 475612.0, 'sum': 862188.0}, '3_posi_4426': {'bp': 470577.0, 'sum': 677143.0}, '13_posi_4429': {'bp': 469731.0, 'sum': 693368.0}, '18_posi_4430': {'bp': 464969.0, 'sum': 694664.0}, 'BLK02_4745': {'bp': 464257.0, 'sum': 660091.0}, '2_posi_4429': {'bp': 452642.0, 'sum': 668880.0}, '8_posi_4429': {'bp': 446769.0, 'sum': 661966.0}, '11_posi_4406': {'bp': 445590.0, 'sum': 667642.0}, '19_posi_4577': {'bp': 438726.0, 'sum': 654223.0}, '17_posi_4451': {'bp': 436218.0, 'sum': 632818.0}, '12_posi_4428': {'bp': 430609.0, 'sum': 631877.0}, 'ProcedureBlank_4513': {'bp': 429769.0, 'sum': 648056.0}, '15_posi_4471': {'bp': 426270.0, 'sum': 612172.0}, 'BLK02_4825': {'bp': 421570.0, 'sum': 604724.0}, '16_posi_4491': {'bp': 420615.0, 'sum': 608928.0}, 'ProcedureBlank_4723': {'bp': 415679.0, 'sum': 573976.0}, 'ProcedureBlank_4807': {'bp': 411920.0, 'sum': 581928.0}, 'ProcedureBlank_4596': {'bp': 405109.0, 'sum': 561970.0}, '17_posi_4535': {'bp': 395902.0, 'sum': 585645.0}, 'BLK02_4934': {'bp': 371058.0, 'sum': 541800.0}}
COMMENT: RETENTION_TIME_STDEV 0.300
COMMENT: PRECURSOR_M/Z_RAW 167.128860
COMMENT: PRECURSOR_M/Z_STDEV 0.000036
COMMENT: PRECURSOR_IN_MS1 mz 167.129191; int 36.261; delta(ppm) 1.305154
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.415; C8H14N4; [M+H]+; delta(ppm) 0.415358
COMMENT: PROPOSED_MF MS-FINDER 2.904; C8H14N4; [M+H]+; delta(ppm) 0.407421
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.087; C8H14N4; [M+H]+; delta(ppm) 0.407421
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.215; C10H16NO; [M+H]+; delta(ppm) -7.626208
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N4; [M+H]+; delta(ppm) 0.407421
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.477; C8H14N4; [M+H]+; delta(ppm) 0.407421
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.813; C5H15FN4O; [M+H]+; delta(ppm) -6.429488
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.980; C10H16NO; [M+H]+; delta(ppm) -7.626208
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.114; C4H17N5P; [M+H]+; delta(ppm) -1.442063
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N4; [M+H]+; delta(ppm) 0.407421
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.814; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; N#CCCNCCNCCC#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.706; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; 3,3'-(ethylenediimino)bispropiononitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; 3,3'-(ethylenediimino)bispropiononitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.576; LBGLYAJNIDZGGO-UHFFFAOYSA-N; [M+H]+; 4-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.486; RHRVANRKEISTIR-UHFFFAOYSA-N; [M+H]+; 3-[2-(2-cyanoethylamino)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.473; OYBUININCBHVPI-UHFFFAOYSA-N; [M+H]+; 1-(1-methylimidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.580; HLVMFESFZBIMBC-UHFFFAOYSA-N; [M+H]+; 3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.510; XIRHPUATWAYWSH-UHFFFAOYSA-N; [M+H]+; 2-[2-[cyanomethyl(methyl)amino]ethyl-methylamino]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; AYEZDNZCTPGJSA-UHFFFAOYSA-N; [M+H]+; 2-[1-(cyclopropylmethyl)triazol-4-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.482; LXSAPEUXYKTICH-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-5-methyltetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.477; AAVVZAZZXUMURZ-UHFFFAOYSA-N; [M+H]+; 2-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.470; DSEMCBZVWDDRJS-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-(methylaminomethyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.469; CEDXNHGVYPISPG-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.467; VIUKMNKXXJAZLD-UHFFFAOYSA-N; [M+H]+; 5-piperidin-4-yl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.460; KAIJJBGBXLAITA-UHFFFAOYSA-N; [M+H]+; 1,3-dimethyl-4,5,6,7-tetrahydropyrazolo[3,4-b]pyridin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.459; VCBYBXAUBOKBSZ-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-4-(methylaminomethyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.442; VCZQHTMMBHUSEO-UHFFFAOYSA-N; [M+H]+; (3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.437; BYVMDDKNSVCZEG-UHFFFAOYSA-N; [M+H]+; 3-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.437; QUTNNKVOFOZWEM-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-N,N,6-trimethylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.427; IACZAGXWNRNOBU-UHFFFAOYSA-N; [M+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.422; VMPRGXHRBMHXOH-UHFFFAOYSA-N; [M+H]+; 4-(5-methyltriazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.420; OAMZBBRGCCAGJL-UHFFFAOYSA-N; [M+H]+; 4-(1H-1,2,4-triazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.402; DVYSYRXOUIBQJG-UHFFFAOYSA-N; [M+H]+; 4-(5-methyl-1H-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.400; HWMQIGXDBKSZNN-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrazol-3-yl)pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.393; FJEIRKHYFRMBAB-UHFFFAOYSA-N; [M+H]+; 3-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.391; IRPFSJQQONMYDX-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.380; MEWCPBOFWYJTNM-UHFFFAOYSA-N; [M+H]+; 1-(5-methyl-1H-pyrazol-3-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.376; LLWRMGZNTZIBOV-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.372; NOOUZWQNFVDCFF-UHFFFAOYSA-N; [M+H]+; 3-azido-9-azabicyclo[3.3.1]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.369; NHOCIKGCQZOHNI-UHFFFAOYSA-N; [M+H]+; 5-cyclohexyl-1-methyltetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.368; PJYAFOPPECXXAT-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.366; VAWCWWMADSCPDU-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.364; AHGXYHGWKDLIPH-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.360; UZBROTQFSPKCTC-UHFFFAOYSA-N; [M+H]+; 1-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.357; OIJPPRAITGSIRG-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.350; JTEUFNQZAUZEGI-UHFFFAOYSA-N; [M+H]+; 3-N,3-N,6-N,6-N-tetramethylpyridazine-3,6-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.345; WQYVPLKUHYMUJI-UHFFFAOYSA-N; [M+H]+; 2-(triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.345; CJEYOZIHKHZSIM-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.342; ZLGCTFLARAWVND-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.338; VMLRMVKKLVMTPX-UHFFFAOYSA-N; [M+H]+; 3-methyl-3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.334; YLICHTZAMDDIIM-UHFFFAOYSA-N; [M+H]+; 2-(4-methyl-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; HADFJARZQWSNHR-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; MBIVPEKQMUQASJ-UHFFFAOYSA-N; [M+H]+; 2-(1H-imidazol-2-yl)-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; RYHAXZZMCHTQKU-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-1-ylmethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; HOSVESHQDSFAST-UHFFFAOYSA-N; [M+H]+; 2-[2-(2-cyanopropan-2-yl)hydrazinyl]-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; PGYXLTZSSAXNND-UHFFFAOYSA-N; [M+H]+; 1-(2-pyrrolidin-1-ylethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -88.463; RHRVANRKEISTIR; [M+H]+; 4,10-dinitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -115.769; XIRHPUATWAYWSH; [M+H]+; (N,N''-Dimethylethylenedinitrilo)diacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.764; PGYXLTZSSAXNND; [M+H]+; 1-(2-pyrrolidin-1-ylethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.022; ZLGCTFLARAWVND; [M+H]+; 4-(1H-1,2,4-triazol-1-ylmethyl)piperidine dihydrochloride
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.810; LLWRMGZNTZIBOV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.468; HOSVESHQDSFAST; [M+H]+; Hydrazodiisobutyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.180; NHOCIKGCQZOHNI; [M+H]+; 5-cyclohexyl-1-methyltetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.628; VIUKMNKXXJAZLD; [M+H]+; 3-piperidin-4-yl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.012; LXSAPEUXYKTICH; [M+H]+; 1-cyclohexyl-5-methyltetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -300.275; JTEUFNQZAUZEGI; [M+H]+; 3,6-Bis(dimethylamino)pyridazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.113; DGCMIDYTTCDSBB; [M+H]+; 2-N,3-N,4-N-trimethylpyridine-2,3,4-triamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.350; RHRVANRKEISTIR; [M+H]+; 4,10-dinitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.367; RHRVANRKEISTIR; [M+H]+; Propanenitrile, 3,3'-(1,2-ethanediyldiimino)bis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.711; HOSVESHQDSFAST; [M+H]+; Hydrazodiisobutyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -133.490; VCZQHTMMBHUSEO; [M+H]+; [(6S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-yl]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.922; XIRHPUATWAYWSH; [M+H]+; N,N'-Dicyanomethyl-N,N'-dimethylethylenediamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -150.833; MBIVPEKQMUQASJ; [M+H]+; (2R)-2-(1H-imidazol-2-yl)-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.131; JTEUFNQZAUZEGI; [M+H]+; 3,6-Bis(dimethylamino)pyridazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -173.284; PGYXLTZSSAXNND; [M+H]+; 1-(2-Pyrrolidinylethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -178.821; IACZAGXWNRNOBU; [M+H]+; 1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.689; LLWRMGZNTZIBOV; [M+H]+; 2-(1-methyl-1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.179; NHOCIKGCQZOHNI; [M+H]+; 1H-Tetrazole, 5-cyclohexyl-1-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.149; RHRVANRKEISTIR; [M+H]+; Propanenitrile, 3,3'-(1,2-ethanediyldiimino)bis-
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C8H15N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 8.939
MS$FOCUSED_ION: PRECURSOR_M/Z 167.129191
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-0900000000-f069dfcaa2d3f5107c4c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  71.0603018 12.0983 71.060915 1.4213 3.03 0.2257 40 f{C3H7N2}/-1.03ppm,p-C5H8N2
  97.0760450 115.2113 97.076390 0.4945 9.33 0.6910 40 f{C5H9N2}/0.21ppm,p-C3H6N2
  99.0916159 12.8026 99.091945 1.8670 3.54 0.2345 38 f{C5H11N2}/-0.59ppm,p-C3H4N2
  121.0842143 94.0143 121.084310 1.6765 128.51 0.7347 31 ?
  124.0868999 33.4046 124.086955 1.3942 6.41 0.1959 40 f{C6H10N3}/-0.19ppm,p-C2H5N1
  126.1025232 17.3798 126.102550 1.3798 4.04 0.0722 40 f{C6H12N3}/-0.40ppm,p-C2H3N1
  138.1025695 36.2300 138.102475 1.3468 5.42 0.5261 40 f{C7H12N3}/-0.03ppm,p-C1H3N1
  139.0973851 12.9317 139.097290 2.1136 2.35 0.2943 35 f{C6H11N4}/-3.15ppm,p-C2H4
  149.0233315 12.2097 149.023230 2.0534 3.44 -0.0129 36 ?
  150.1024722 15.2940 150.102370 1.6722 4.00 0.1664 38 f{C8H12N3}/-0.68ppm,p-H3N1
  167.0812631 37.3978 167.081150 2.6394 10.55 -0.2081 35 ?
  167.0927031 25.6355 167.092590 2.7051 8.64 0.4038 34 ?
  167.1291632 999.0000 167.129050 0.2513 0.00 1.0000 40 f{C8H15N4}/0.24ppm,p
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  71.060302 12.10 12
  97.076045 115.21 115
  99.091616 12.80 12
  121.084214 94.01 94
  124.086900 33.40 33
  126.102523 17.38 17
  138.102569 36.23 36
  139.097385 12.93 12
  149.023332 12.21 12
  150.102472 15.29 15
  167.081263 37.40 37
  167.092703 25.64 25
  167.129163 999.00 999
//
